Laurence Arnold, PhD

Pelago Bioscience, Stockholms Lan, Sweden

Laurence completed his PhD and post-doctoral studies utilising biochemical and biophysical methods for structural and functional studies of proteins. Moving into the drug discovery world using these approaches in the assay development group at Lifearc, Stevenage, UK. Currently he heads the R&D department at Pelago Bioscience in Stockholm where the focus is on characterizing proteins in a physiologically relevant environment to assess target engagement with CETSA technologies.

Disclosure information not submitted.

Presentation(s):

• Screen Design and Assay Technology

  Monday, February 5, 2024
  1:00 PM – 2:00 PM EST

• CETSA® HT: Employing rapid high-throughput target engagement technology in primary screening of P53

  Tuesday, February 6, 2024
  4:00 PM – 4:30 PM EST